Ardelyx appoints Sue Hohenleitner as CFO

* Ardelyx (NASDAQ:ARDX [https://seekingalpha.com/symbol/ARDX]) announced on Monday the appointment [https://seekingalpha.com/pr/20263197-ardelyx-appoints-experienced-finance-executive-sue-hohenleitner-as-chief-financial-officer] of Sue Hohenleitner as Chief Financial Officer (CFO [https://seekingalpha.com/symbol/CFO]), effective November 4, 2025.
* Hohenleitner most recently served as the Vice President and Chief Financial Officer of Johnson & Johnson (J&J) Innovative Medicine North America, leading financial strategies for a $36 billion commercial business.

MORE ON ARDELYX

* Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4820423-ardelyx-inc-ardx-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference]
* Ardelyx, Inc. (ARDX) Presents at Citi's Biopharma Back to School Conference - Slideshow [https://seekingalpha.com/article/4819294-ardelyx-inc-ardx-presents-at-citis-biopharma-back-to-school-conference-slideshow]
* Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript [https://seekingalpha.com/article/4819119-ardelyx-inc-ardx-presents-at-citis-biopharma-back-to-school-conference-transcript]
* Ardelyx raises 2025 IBSRELA revenue guidance to $250M–$260M amid sustained demand growth [https://seekingalpha.com/news/4478032-ardelyx-raises-2025-ibsrela-revenue-guidance-to-250m-260m-amid-sustained-demand-growth]
* Ardelyx appoints Edward Conner as Chief Medical Officer [https://seekingalpha.com/news/4478001-ardelyx-appoints-edward-conner-as-chief-medical-officer]